Hoshino Akihiro
Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.
Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Institut National de la Sante et de la Recherche Medicale UMR 1163.
Rinsho Ketsueki. 2018;59(10):2195-2203. doi: 10.11406/rinketsu.59.2195.
Primary immunodeficiencies (PIDs) are inherited disorders caused by an impaired immune system. Because the immune system effects various immune reactions, PIDs present various clinical phenotypes including increased susceptibility to infections, autoimmunity, and malignancies. For adequate diagnosis of PIDs, a systematic approach using clinical genetic sequencing is required. New technologies including next-generation sequencing have become widely available and have led to the identification of novel genetic defects underlying PIDs. In the clinical setting, the identification of genes responsible for impaired immune system function for each PID enables the proposition of more disease-specific treatment options that target the affected signaling pathway. Research on PIDs not only benefits clinical treatment, it also provides a deeper understanding of the human immune system.
原发性免疫缺陷病(PIDs)是由免疫系统受损引起的遗传性疾病。由于免疫系统影响各种免疫反应,原发性免疫缺陷病呈现出多种临床表型,包括对感染、自身免疫和恶性肿瘤的易感性增加。为了对原发性免疫缺陷病进行充分诊断,需要采用临床基因测序的系统方法。包括下一代测序在内的新技术已广泛应用,并导致发现了原发性免疫缺陷病潜在的新基因缺陷。在临床环境中,确定每种原发性免疫缺陷病中负责免疫系统功能受损的基因,有助于提出更多针对受影响信号通路的疾病特异性治疗方案。对原发性免疫缺陷病的研究不仅有益于临床治疗,还能加深我们对人类免疫系统的理解。